Foralumab

Foralumab (TZLS-401), being researched by Tiziana Life Sciences ) is a fully human monoclonal antibody that binds to CD3 epsilon of the T cell receptor-CD3 complex.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Foralumab (TZLS-401), being researched by Tiziana Life Sciences ) is a fully human monoclonal antibody that binds to CD3 epsilon of the T cell receptor-CD3 complex. It is currently being studied in a randomized, double-blind placebo-controlled, multicenter dose-ranging study in a nasal formulation in patients with non-active secondary progressive multiple sclerosis (SPMS).

Text derived from https://en.wikipedia.org/w/index.php?oldid=1314089627 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

4 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.